Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

[Business Wire] – NEW YORK & SEOUL, South Korea–(BUSINESSWIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and Samsung BioLogics today announced the companies will increase the scope of their existing manufacturing agreement … Read more on . . . → Read More: Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement Similar Articles: Company Update (NYSE:BMY): Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1 Market Update (NYSE:BMY): Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to US FDA for the Treatment of Hepatitis C Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade